";s:4:"text";s:3604:" This starts with an infection of your intestine or urinary tract. Adalimumab therapy was discontinued in 4 patients. Aetna considers the Anser ADA test and Miraca Life Sciencesâ InformTx therapeutic drug monitoring (TDM) for persons being treated with adalimumab experimental and investigational because the effectiveness of this approach has not been established. However, based on the amount of evidence, infliximab and adalimumab were the most effective agents. A total of 15 patients participated in the study (12 girls; mean patient age of 12 years). The authors reviewed the therapeutic effects of the 2 most widely used anti-TNF-α molecules, infliximab (a fusion protein dimer of the human TNF-α receptor) and adalimumab (a fully human monoclonal antibody to TNF-α), for the treatment of the major cutaneous manifestations associated with IBD (EN, PG and psoriasis). The FDA approval of Humira was based on 2 multi-center randomized controlled clinical studies evaluating the safety and efficacy of adalimumab compared with placebo in 413 patients with moderate to severely active psoriatic arthritis (greater than 3 swollen and greater than 3 tender joints) who have had an inadequate response to non-steroidal anti-inflammatory drugs (NSAIDS). Joint inflammation is characterized by redness, swelling, pain and warmth in and around the affected joint. At the same time points patients evaluated disease activity by visual analog scale (VAS).